Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of dopamine receptor sites labeled by (/sup 3/H)-S-sulpiride and (/sup 3/H)-spiperone in striatum

Journal Article · · J. Pharmacol. Exp. Ther.; (United States)
OSTI ID:6541754

Binding of the radiolabeled active isomer of the neuroleptic sulpiride, (/sup 3/H)-S-sulpiride, to rat and rabbit striatal membranes was characterized. Regardless of whether the specific binding of (/sup 3/H)-S-sulpiride was defined with spiperone or the active isomers of butaclamol or flupenthixol, a single homogeneous++ population of binding sites (rat: Kd . 5.6 nM, maximum binding . 590 fmol/mg of protein; rabbit: Kd . 8.3 nM, maximum binding . 540 fmol/mg of protein) was detected. The pharmacological profile of these sites was characteristic of that described for the dopaminergic D-2 receptor subtype. To determine whether (/sup 3/H)-S-sulpiride and (/sup 3/H)spiperone label common sites in the striatum, the binding of these two radioligands was compared under similar assay conditions. When specific binding of (/sup 3/H)spiperone was defined with S-sulpiride, (/sup 3/H)spiperone labeled the same number of binding sites as (/sup 3/H)-S-sulpiride despite the fact that the affinity of the sites for (/sup 3/H)spiperone was 80- to 90-fold higher than for (/sup 3/H)-S-sulpiride. When specific binding of (/sup 3/H)spiperone was defined with either (+)-butaclamol or (alpha)-flupenthixol, however, approximately 30% more sites were labeled. The predominant site labeled by (/sup 3/H)spiperone also possessed the characteristics of the D-2 receptor. It is concluded that (/sup 3/H)-S-sulpiride under the conditions used is a selective radioligand with which dopamine receptors of the D-2 subtype can be directly measured and localized. (/sup 3/H)Spiperone can be used to detect the same sites only if specific binding is defined with S-sulpiride.

Research Organization:
Univ. of Colorado School of Medicine, Denver
OSTI ID:
6541754
Journal Information:
J. Pharmacol. Exp. Ther.; (United States), Journal Name: J. Pharmacol. Exp. Ther.; (United States) Vol. 227:3; ISSN JPETA
Country of Publication:
United States
Language:
English